Dr. Michael T. Mineo, MD

Dr. Mineo practices at HMU Surgical Center in Houston, Texas.

Dr. Mineo's NPI, 1801849385, was assigned on May 18, 2006. Dr. Mineo graduated from McGovern Medical School at UTHealth in 1999. Dr. Mineo holds Texas license L5056.

Dr. Mineo's primary practice is HMU Surgical Center, at 4219 Richmond Ave, Suite 100, Houston, TX 77027. The practice phone is (713) 634-4433.

Dr. Mineo's primary practice is HMU Surgical Center in Houston, Texas. Dr. Mineo is also affiliated with Memorial Hermann-Texas Medical Center. The medical group on file is Houston Metro Urology. Dmand AI also links Dr. Mineo to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mineo practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Mineo's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Mineo is board certified in urology by the American Board of Urology. Dr. Mineo is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Mineo treats.

CMS data shows 21,824 Medicare services from Dr. Mineo across 30 procedure codes in 2024, for 840 Medicare patients. Medicare paid $243,904 for them.

CMS counts 840 Medicare patients who saw Dr. Mineo in 2024. The largest group is 65 to 74, with 368 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mineo's median patient age at 71, with 13% women.

In 2024, Dr. Mineo wrote 3,495 Medicare Part D claims for 717 patients. 82% of them were for generic drugs. CMS names the drug for 3,311 of them, across 37 drugs with 11 or more claims each, at $1,471,031 in total drug cost. In 2023, CMS named 2,876 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Mineo for performance year 2024, reported as part of a group. Dr. Mineo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mineo as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Mineo, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Mineo, published from 2009 to 2010. The most frequent topics are Cell Culture Techniques, Estrogens and Mammary Glands, Animal. Dr. Mineo's most frequent co-authors are Ziya Levent Gokaslan, MD, Stephen J. Incavo, MD and Dietrich Jehle, MD.

CMS Open Payments shows 831 general payments to Dr. Mineo from 81 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. PROCEPT BioRobotics Corporation paid the most, $7,085.

Dmand AI lists 1 award for Dr. Mineo, most recently CMS Stage 1 2012 in 2011.

Dr. Mineo graduated from McGovern Medical School at UTHealth in 1999.

Dr. Mineo is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.